시장보고서
상품코드
1152248

세계의 게노믹스 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품 및 서비스별, 기술별, 용도별, 최종 사용자별, 기업별, 지역별(2017-2027년)

Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services, By Technology, By Application, By End User, By Company, and By Region

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 117 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 게노믹스 시장은 예측 기간 중 2023-2027년에 눈부신 성장을 이룰 것으로 예측되고 있습니다.

성장의 주요 요인으로는 특수한 의약품 증가, 다양한 분야에서의 게노믹스의 폭넓은 응용 등이 있습니다.

현재 유전성 질환과 만성 질환으로 고통받는 것으로 진단된 사람들을 위해 개인화 의료에 대한 수요가 급증하고 시장 성장을 촉진하고 있습니다. 또한 진단기술의 진보, 정부에 의한 투자 확대, 암 이환율의 상승, 연구개발 이니셔티브의 활발화 등도 시장 성장을 지원하는 요인이 되고 있습니다.

세계의 게노믹스(Genomics) 시장에 대해 조사 분석했으며, 부문별·지역별 시장 규모/점유율 예측/시장 역학/기업 개요 등 체계적인 정보를 제공하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계의 게노믹스 시장에 대한 COVID-19의 영향

제4장 VOC(고객의 목소리)

제5장 주요 요약

제6장 세계의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별(시스템, 소프트웨어, 소모품, 서비스)
    • 기술별(시퀀싱, PCR, 핵산 추출·정제, 마이크로어레이, 기타)
    • 용도별(창약·개발, 진단, 농업·동물 연구, 기타)
    • 최종 사용자별(병원·클리닉, 학술·연구기관, 바이오테크놀로지·제약회사, 기타)
    • 기업별(2021년)
    • 지역별
  • 시장 맵

제7장 북미의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 유럽의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 아시아 태평양의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 아시아 태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제10장 남미의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동·아프리카의 게노믹스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카
    • 사우디 아라비아
    • 아랍 에미리트 연방
    • 이집트
    • 터키

제12장 시장 역학

  • 촉진 요인
  • 과제

제13장 시장 동향과 개발

제14장 경쟁 상황

  • Illumina, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Myriad Genetics, Inc.
  • 23andMe, Inc.
  • Eppendorf AG
  • Quest Diagnostics Inc.

제15장 전략적 제안

LYJ 22.11.24

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing specialized medicines and wide application of genomics in numerous areas. Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes. Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes. Nowadays, people are diagnosed with genetic as well as chronic diseases due to which demand for personalized medicine is surging, which is bolstering the growth of the market. The other factors supporting the market's growth are, advancement in diagnostic techniques, increasing investments by governments, surge in cancer incidents and rise in R&D initiatives.

Increasing Demand of Specialized/Personalized Medicine

Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market. The ability to advance health care facilities by providing unique clinical, genetic, genomic, and environmental information is increasing the importance of genomics. Surging demand of Personalized medicines is due to their efficiency to treat unique, yet complex diseases. They help medical researchers to identify the exact requirement of patient and then treat them accordingly. Based on the 2020 Scope and Significance of Progress report, personalized medicines accounted for around 39 percent of the total FDA-approved new drugs in the year. Doctors, researchers, and pharmaceutical firms are using precision medicine for developing new drug and disease therapies, and unique clinical testing. Personalized medicine uses all genes in human genome for identification, prevention, and treatment of any complex disease.

Growing Application of Genomics in Various Sectors.

The use of genomics concepts in the field of synthetic biology, healthcare, study gene sequences of plants and organisms, and bioengineering sectors are some of the applications, which is anticipating the growth of the market. For instance, agricultural genomics is a field that is contributing to advances in crop development such as it can lessen the trials and failures involved in scientific research to a certain extent, which could enhance the quality and quantity of crop yields in agriculture. In December 2020, Calyxt, Inc. announced signing a research collaboration with NRGene Ltd. that comprises the use of the cloud-based genomic platform of NRGene to fast-track hemp trait discovery.

Technological Advancements

Rapid advancements and innovations in the genomics sector are bolstering the growth of the market. The advent of cheaper nucleic acid sequencing is modifying DNA and RNA on demand. Sensing the increasing demand several companies are offering sequencing services for nutrition, ancestry, and genetic diseases. Rapid advances in microscopy are also in process. For instance, in 2019, Thermo Fisher Scientific, Inc. (US) introduced the Oncomine Precision Assay, an innovative pan-cancer panel, for its Genexus platform to advance precision medicine in clinical settings. Other factors, such as massive research and development (R&D) activities in the bioinformatics sector and the increasing demand for next-generation sequencing services, are anticipating the growth of the market.

Market Segmentation

The global genomics market is segmented into products & services, technology, application, end user, and company. Based on products & services, the market is divided into systems & software, consumables, and service. Based on technology, the market is divided into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on application, the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. Based on end user, the market is divided into hospitals & clinics, academic & research institutions, biotechnology & pharmaceutical companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising importance of personalized medicines and wide application of genomics in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global genomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Genomics Market, By Products & Services:

  • Systems & Software
  • Consumables
  • Service

Genomics Market, By Technology:

  • Sequencing
  • PCR
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Others

Genomics Market, By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Agriculture & Animal Research
  • Others

Genomics Market, By Application:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Biotechnology & Pharmaceutical Companies
  • Others

Genomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Genomics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Genomics Market

4. Voice of Customer

5. Executive Summary

6. Global Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services (Systems & Software, Consumables, Service)
    • 6.2.2. By Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Others)
    • 6.2.3. By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Others)
    • 6.2.4. By End User (Hospitals & Clinics, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Genomics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product & Services
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Genomics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product & Services
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Genomics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products & Services
    • 11.2.2. By Technology
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Genomics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product & Services
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Genomics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product & Services
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Genomics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product & Services
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Genomics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product & Services
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Turkey Genomics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product & Services
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Illumina, Inc.
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. QIAGEN N.V.
  • 14.4. Agilent Technologies, Inc.
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Bio-Rad Laboratories, Inc.
  • 14.7. Eurofins Scientific SE
  • 14.8. Oxford Nanopore Technologies Limited
  • 14.9. Pacific Biosciences of California, Inc.
  • 14.10. Danaher Corporation
  • 14.11. GE Healthcare
  • 14.12. Myriad Genetics, Inc.
  • 14.13. 23andMe, Inc.
  • 14.14. Eppendorf AG
  • 14.15. Quest Diagnostics Inc.

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제